Versant Ventures
51 portfolio companies · 5 on the map · $1.3B raised · 5 cities
Portfolio map
5 Versant Ventures portfolio companies on the map.
Portfolio companies

CRISPR Therapeutics
Boston
CRISPR Therapeutics is focused on the development of transformative medicines using its proprietary CRISPR/Cas9 gene-editing platform.
Biotechnology Research$957MEst. 2013
LENZ THERAPEUTICS
San Diego
LENZ Therapeutics operates as an organization engaged in the late-stage clinical development of pharmaceuticals for the eyes.
Pharmaceutical Manufacturing$217.4MAmphora Discovery
Durham
Amphora Discovery Corporation operates as a biotechnology company.
Biotechnology Research$94.3MEst. 2001
NEUROTECH U S A
Cumberland
Neurotech is a biotechnology company developing sight-saving therapeutics for chronic retinal diseases.
Biotechnology Research$49.1MNeuWave Medical
Madison
Johnson & Johnson Medtech helps the healthcare industry by providing surgery and orthopedics-related products.
More portfolio companies
45 more Versant Ventures investments we track beyond the map — 51 tracked in total.
Tempest TherapeuticsSan Francisco · Post-IPO Equity
Firefly BioSan Francisco · Series A
Repare TherapeuticsSaint Laurent · Series B
Tentarix BiotherapeuticsSan Diego · Series B
Monteris MedicalMinnetonka · Series C
NuvairaMinneapolis · Series E
Borealis BiosciencesVancouver · Series A
Capsida BiotherapeuticsNewbury Park · Series A
Jazz PharmaceuticalsPalo Alto · Series B
Helicore BiopharmaSan Mateo · Series A
Ventus TherapeuticsWaltham · Series C
HalioHayward · Series D
T-knifeBerlin · Series B
Light Horse TherapeuticsSan Diego · Series A
Venatorx PharmaceuticalsMalvern · Series B
Hicuity HealthSt Louis · Series D
Black Diamond TherapeuticsCambridge · Series C
Tarveda TherapeuticsWatertown · Series D
Passage BioPhiladelphia · Series B
Standard BioToolsSouth San Francisco · Venture
Inari MedicalIrvine · Series C
RespicardiaMinnetonka · Venture
SebaciaDuluth · Series D
AnokionEcublens · Series B
Bird Rock BioLa Jolla · Series B
OraMetrixRichardson · Series C
CymaBay TherapeuticsHayward · Series E
Chinook TherapeuticsVancouver · Post-IPO Equity
Pandion TherapeuticsCambridge · Series B
Oyster Point PharmaceuticalsSan Francisco · Series B
InogenGoleta · Series E
Five Prime TherapeuticsSan Francisco · Private Equity
ForteBioMenlo Park · Series C
The FoundryMenlo Park · Series A
Skylight Healthcare SystemsSan Diego · Series B
NeoGuide SystemsSan Jose · Series B
ParAllele BioscienceWaltham · Convertible Note
Inception SciencesSan Diego · Series A
RedBrick HealthMinneapolis · Venture
Vantage OncologyManhattan Beach · Series D
Cameron HealthSan Clemente · Series E
- NNovaceaSan Francisco · Series C
NeoVistaNewark · Venture
MedManage SystemsBothell · Series E
Accelerator Corp.Seattle · Venture
Portfolio map
5 Versant Ventures portfolio companies on the map.